These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9236409)

  • 1. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.
    Kapiotis S; Jilma B; Quehenberger P; Ruzicka K; Handler S; Speiser W
    Circulation; 1997 Jul; 96(1):19-21. PubMed ID: 9236409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diurnal variations in coagulation and fibrinolysis in vital exhaustion.
    van Diest R; Hamulyák K; Kop WJ; van Zandvoort C; Appels A
    Psychosom Med; 2002; 64(5):787-92. PubMed ID: 12271109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of blood coagulation and fibrinolysis in diabetes mellitus: evaluation by plasma levels of thrombin-antithrombin III complex and plasmin-alpha 2-plasmin inhibitor complex.
    Takahashi H; Tsuda A; Tatewaki W; Wada K; Niwano H; Shibata A
    Thromb Res; 1989 Sep; 55(6):727-35. PubMed ID: 2528845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
    Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
    Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjects.
    Brunner-Ziegler S; Jilma B; Schörgenhofer C; Winkler F; Jilma-Stohlawetz P; Koppensteiner R; Quehenberger P; Seger C; Weigel G; Griesmacher A; Brunner M
    J Thromb Haemost; 2016 Feb; 14(2):316-23. PubMed ID: 26644369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients.
    Hryszko T; Malyszko J; Malyszko JS; Brzosko S; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Aug; 16(8):1692-6. PubMed ID: 11477176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis.
    Bladbjerg EM; Münster AM; Marckmann P; Keller N; Jespersen J
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2494-9. PubMed ID: 11073858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects.
    Weiss C; Seitel G; Bärtsch P
    Med Sci Sports Exerc; 1998 Feb; 30(2):246-51. PubMed ID: 9502353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
    Maeda M; Kachi H; Kitajima Y
    J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K; Fujimaki M
    Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates.
    Hellstern P; Beeck H; Fellhauer A; Fischer A; Faller-Stöckl B
    Thromb Res; 1997 Jun; 86(6):493-504. PubMed ID: 9219329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of perioperatively administered crystalloids and colloids on concentrations of molecular markers of activated coagulation and fibrinolysis.
    Fries D; Streif W; Margreiter J; Klingler A; Kühbacher G; Schobersberger W; Wirleitner B; Innerhofer P
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):213-9. PubMed ID: 15060416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostasis in newborns of smoking and nonsmoking mothers.
    Mercelina-Roumans PE; Ubachs JM; van Wersch JW
    Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autotransfusion in coronary artery bypass grafting: disparity in laboratory tests and clinical performance.
    Flom-Halvorsen HI; Ovrum E; Tangen G; Brosstad F; Ringdal MA; Oystese R
    J Thorac Cardiovasc Surg; 1999 Oct; 118(4):610-7. PubMed ID: 10504624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia.
    Cardigan RA; Crook M; Mackie IJ; Machin SJ
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):187-92. PubMed ID: 11414632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of 17 beta-oestradiol on variables of coagulation and fibrinolysis in postmenopausal women with type 2 diabetes mellitus.
    Brussaard HE; Leuven JA; Krans HM; Kluft C
    Vascul Pharmacol; 2002 Aug; 39(3):141-7. PubMed ID: 12616982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive fibrinolysis in suspected amyloidosis: demonstration of plasmin-alpha 2-plasmin inhibitor complex and von Willebrand factor fragment in plasma.
    Takahashi H; Koike T; Yoshida N; Kitahara O; Hanano M; Shibata A; Aoki N
    Am J Hematol; 1986 Oct; 23(2):153-66. PubMed ID: 2944378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.